Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.
about
Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric DisordersMetabolomics in pancreatic cancer biomarkers research.Metabolomic analysis identifies differentially produced oral metabolites, including the oncometabolite 2-hydroxyglutarate, in patients with head and neck squamous cell carcinoma.
P2860
Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Metabolic tumor burden: a new ...... personalized therapy in PDAC.
@en
type
label
Metabolic tumor burden: a new ...... personalized therapy in PDAC.
@en
prefLabel
Metabolic tumor burden: a new ...... personalized therapy in PDAC.
@en
P2093
P1433
P1476
Metabolic tumor burden: a new promising way to reach precise personalized therapy in PDAC
@en
P2093
Chuntao Wu
Huaxiang Xu
Jiang Long
Jinfeng Xiang
Quanxing Ni
Wenquan Wang
P304
P356
10.1016/J.CANLET.2015.01.023
P407
P50
P577
2015-01-21T00:00:00Z